Cas:109794-97-0 Harmalidine manufacturer & supplier

We serve Chemical Name:Harmalidine CAS:109794-97-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Harmalidine

Chemical Name:Harmalidine
CAS.NO:109794-97-0
Synonyms:8-Methoxy-2,2-dimethyl-1,2,4,5-tetrahydro-3,9b-diazacyclopenta[jk]fluorene;Benzo[b]pyrido[2,3,4-gh]pyrrolizine, 1,2,4,5-tetrahydro-8-methoxy-4,4-dimethyl-
Molecular Formula:C16H18N2O
Molecular Weight:254.327
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:412.6±45.0 °C at 760 mmHg
Density:1.3±0.1 g/cm3
Index of Refraction:1.663
PSA:26.52000
Exact Mass:254.141907
LogP:1.84

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 8-Methoxy-2,2-dimethyl-1,2,4,5-tetrahydro-3,9b-diazacyclopenta[jk]fluorene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzo[b]pyrido[2,3,4-gh]pyrrolizine, 1,2,4,5-tetrahydro-8-methoxy-4,4-dimethyl- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Benzo[b]pyrido[2,3,4-gh]pyrrolizine, 1,2,4,5-tetrahydro-8-methoxy-4,4-dimethyl- Use and application,8-Methoxy-2,2-dimethyl-1,2,4,5-tetrahydro-3,9b-diazacyclopenta[jk]fluorene technical grade,usp/ep/jp grade.


Related News: The Big Pharma had, however, decided to all but shelve donanemab in the near term as it couldn’t see a regulatory path forward. Harmalidine manufacturer In a memo to Branchburg employees on May 20, Nellie Clark, head of the plant, summed up the outside lawyers’ findings: “In the end and very importantly, allegations that Lilly made false statements to the FDA were not substantiated.” Harmalidine supplier Darzalex does have another regimen approved for the same myeloma population. Darzalex combined with Takeda’s Velcade, melphalan and prednisone (VMP) reduced the risk of death by 40% in the phase 3 ALCYONE trial. But disease progression had already occurred in half of patients on the Darzalex-VMP combo after about three years of follow-up, a much shorter period than the five-year mark the Darzalex-Rd regimen is approaching. Harmalidine vendor We partner with life science companies of all sizes, drawing on over 20 years of industry experience. Harmalidine factory The Big Pharma had, however, decided to all but shelve donanemab in the near term as it couldn’t see a regulatory path forward.